Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...
Improved analytical techniques mean tiny amounts of endocrine disrupting compounds or PFAS can be found in many places. But ...
Eran Ovadya, NurExone’s CFO, expressed: “we sincerely appreciate the trust our investors have placed in us. The warrant exercises and private placement have generated slightly more than C$1.2 million, ...
The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...
AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...
A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency ...
A new monitoring platform developed by the EU’s medicine agency (EMA) is expected to change ... drug availability are often underreported to medicines agencies across Europe or reports are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback